FindTrial
Sign In

Effect of H. pylori eradication therapy in iron deficiency anemia of pregnancy- a randomized double blind placebo controlled clinical trial

RANDOMISED PLACEBO CONTROLLED TRIAL OF HELICOBACTER PYLORI ERADICATION ON TREATMENT OF IRON DEFICIENCY ANEMIA IN PREGNANT WOMEN ? A PILOT STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/001277
Enrollment
40
Registered
2010-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Iron and Folic acid tablets: ferrous sulphate, elemental iron 100 mg plus folic acid 0.5 mg Intervention2: Anti Helicobacter pylori therapy: Cap amoxicillin 1gm BD, Tab clarithromycin 5

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Period of gestation between 14 to 30 weeks,Mild to Moderate Iron deficiency anemia,Presence of H.pylori infection (as detected by stool antigen testing)and Willing to comply with drug therapy

Exclusion criteria

Exclusion criteria: Severe anemia (Hb < 7gm %),Megaloblastic, normocytic normochromic anemia, dimorphic anemia, Known drug allergy or intolerance to oral iron therapy, Known bleeding diathesis or History of antibiotics and/or antacids taken in the past one month

Design outcomes

Primary

MeasureTime frame
Change of Hemoglobin(Hb),Packed cell volume(PCV), Red cell counts(RBC), Mean corposcular volume(MCV), Mean corposcular hemoglobin(MCH), Mean corposcular hemoglobin concentration(MCHC), reticulocyte count, platelet counts, total leucocyte count(TLC),Serum Iron,Serum total iron binding capacity, Transferrin saturation. TIMEPOINT FOR ALL OF ABOVE 6 WEEKSTimepoint:—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactKIRAN GULERIA

UCMS AND GTB Hospital, Dilshad garden,DELHI

kiranguleria@yahoo.co.in01122586262

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026